Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2010 - 01 - 22

PRESS RELEASE - Handbook for asthmatic patients

Asthma is a pathology that affects 4.5% of the population in Italy.
Despite being a life-threatening disease, if appropriately diagnosed and treated, patients can still lead a completely normal life and even play sport on an agonistic level.
Nevertheless, as revealed by recent studies, 25% of patients, do not believe they know enough about their asthma.
In order to help asthmatic patients gain more in-depth knowledge of their disease, Menarini, a leading Italian pharmaceutical company worldwide, and the Italian Society of Respiratory Medicine have cooperated to draw up the "handbook for asthmatic patients", containing 10 key messages about asthma that all patients should be aware of.

The handbook, the full text of which is available on the Menarini website,, highlights the following key points: What to do in the case of an asthma attack; Periodic medical check-ups; What to do at the onset of asthma symptoms; Asthma symptoms; How to change your lifestyle; Factors that trigger as asthma; How to use the aerosol dispensers; What it means to keep asthma under control; Asthma is a chronic disease; What is the purpose of anti-asthma treatment.

Menarini, always interested in patients’ needs, promotes initiatives in all its branches aimed at helping patients to know their disease, to live with it in a stress-free manner and to use the anti-asthma drugs correctly.

The ten points that every asthma patient must know
  1. What to do in the case of an asthma attack
    Severe asthma attacks may be life-threatening. Treatment of asthma attacks, especially of severe or persistent, must be carried out under medical supervision.
    Asthmatic patients must always carry a short-acting bronchodilator (e.g. salbutamol) with them to be used in the event of an asthma attack (2-4 puffs every 20 minutes, as many as 3 times during the first hour). The use of drugs as required must be limited to controlling occasional symptoms. If the day-time symptoms occur more than twice a week, and it is necessary to use the drug as required more than twice a week, the basic asthma treatment must be reassessed and /or implemented.
  2. Periodic medical check-upsAsthma is a chronic and variable disease.
    Home asthma monitoring systems include a clinical diary and measuring of the peak expiratory flow (PEF). By filling out the Asthma Control Test (ACT) questionnaire, patients are able to assess the level of control reached themselves.
    Clinical measures include medical check-ups, spirometry, measuring of bronchial reactivity, and dosing of inflammatory markers. The frequency of the check-ups must be agreed to with the doctor depending on the nature of the asthma, its therapy and the current therapy.
  3. What to do at the onset of asthma symptoms
    The guidelines foresee a gradual approach and therefore the dose and type of the drugs prescribed must be modified according to the level of asthma control reached.
    If the day-time symptoms occur more than twice a week, if there are also night-time symptoms, and if it is necessary to use the drug as required more than twice a week, the basic asthma treatment must be reassessed. The patient, together with the doctor, must agree on how to adapt the treatment according to the level of control of the patient’ asthma.
  4. Asthma symptoms
    The most frequent and common symptoms of asthma are: breathlessness (dyspnoea), cough, wheezing, a sense of chest constriction, both at rest and after physical exertion.
    These symptoms may occur without warning, they may last for a few minutes or even days, they may clear up spontaneously or after treatment, they may be episodic or continual, seasonal or present throughout the year. The characteristics of asthma are its variability in terms of frequency and duration of the symptoms, of being triggered by specific factors, worsening at night, and responding to pharmacological treatment. In some patients the only symptom may be a dry, irritating cough, or wheezing only after physical exertion.
  5. How to change your lifestyle
    When correctly diagnosed and treated, asthma should not limit the patient’s life. By knowing the cause of your own asthma you will be able to take preventive measures (purifying the environment of allergies from mites, premedication before sporting activities, etc.) and implementation of the most suitable treatment. To achieve and maintain a good control of asthma it is important to adopt a healthy lifestyle by not smoking, carrying out regular physical activity, keeping body weight under control and taking medicinal products regularly.
  6. Factors that trigger asthma
    Asthma symptoms may be induced or triggered by a variety of specific elements (e.g. allergen, drugs, gastro-oesophageal reflux, etc.)
    Asthma symptoms may be induced by nonspecific elements (e.g. viral infections, cigarette smoke, atmospheric pollution, irritant chemical substances, the cold, physical exertion, etc.).
    It is essential for every patient to know the factors that could trigger an asthma attack and eliminate them, or if not possible, reduce them to a minimum.
  7. How to use aerosol dispensers
    Inhalation treatment allows the drug to directly reach the target organ, and if implemented correctly, reduce the risk of systemic effects. Today there are numerous inhalators available on the market and despite having different properties, they all offer adequate administration of the drug. Individual preference and user-friendliness may influence the effectiveness of the drug, compliance with the treatment and control of the disease in the long term. It is essential carefully read the illustrative leaflet accompanying the inhaler and check with your doctor that you are using it correctly.
  8. What it means to keep asthma under control
    Asthma is under control when there are no symptoms (or at least minimal symptoms), no flare-ups (or at least very rare flare-ups), no emergency visits or hospitalisation due to asthma, no need (or minimal) for additional use of the bronchodilator as required, no curtailing of daily activities (including physical and sporting activities), and when there is a daily variation in the Peak Expiratory Flow (PEF) of less than 20% and normal spirometric values (or the best possible). Scientific evidence demonstrates that with pharmacological treatment, these goals can easily be achieved in the majority of patients
  9. Asthma is a chronic disease
    Asthma is a persistent/chronic disease: this means that it can be controlled but not cured.
    Moreover, asthma is a variable disease, characterised by stages of worsening when the symptoms appear (asthma attacks or asthma flare-ups), which alternate with periods of complete wellbeing. Persistent asthma is an inflammatory disease, and therefore treatment must be continued even in the absence of symptoms.
  10. What is the purpose of anti-asthma treatment
    Asthma therapy foresees the use of basic drugs and drugs to be used as required.
    The former (corticosteroid inhalers, long-acting bronchodilators, antileukotrienic drugs, theophyllines, chromones, anti IgE monoclonal antibodies) are drugs taken in an ongoing manner for the purpose of clinically keeping the asthma under control, thanks to their anti-inflammatory and/or bronchodilator effect. The drugs to be used as required for relieving the symptoms (short-acting bronchodilators) do not have any effect on the inflammation and the need to use them frequently means that the basic therapy (if already administered) is not sufficient for controlling the disease and must be changed and/or implemented.
    Cortisones to be taken via normal means (tablets, vials, etc.) are drugs to be reserved in case of severe asthma attacks or severe asthma flare-ups; in view of their long-term side effects, the use of these drugs should in any case be limited as much as possible.

Visit the page dedicated to asthmatic patients